| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 42, 852-856, Copyright © 1995 by Canadian Anesthesiologists' Society
ARTICLES |
Y Fujii, H Tanaka and H Toyooka
Department of Anaesthesia, Toride Kyodo General Hospital, Ibaraki, Japan.
The effects of granisetron for preventing postoperative nausea and vomiting were investigated in a randomized, double-blind comparison with droperidol and placebo in 100 patients undergoing general anaesthesia for major gynaecological surgery. The patients received a single dose of either granisetron (40 micrograms x kg(-1), n = 25), droperidol (1.25 mg, n = 25; 2.5 mg n = 25) or placebo (saline, n = 25)iv over two to five minutes immediately before induction of anaesthesia. The antiemetic effects of these drugs were evaluated during the first three and the next 21 hr after recovery from anaesthesia. During 0-3 hr after anaesthesia, the frequency of nausea and vomiting was 60%, 12%, 16% and 12% after administration of placebo, granisetron, droperiodol 1.25 mg or droperidol 2.5 mg, respectively. The corresponding frequencies during 3-24 hr after anaesthesia were 44%, 8%, 36% and 12%. The efficacy of granisetron in preventing postoperative nausea and vomiting was almost equal to that of droperidol 2.5 mg. The awakening time in the patients who had received droperidol 2.5 was prolonged by approximately three minutes compared with the placebo group (P <0.05), and postoperative drowsiness/sedation was observed in these patients. In conclusion, preoperative prophylactic administration of granisetron is superior to that of droperidol in the prevention of postoperative nausea and vomiting after anaesthesia.
This article has been cited by other articles:
 |
|
 |
|
  A. L Kovac Meta-Analysis of the Use of Rescue Antiemetics Following PONV Prophylactic Failure with 5-HT3 Antagonist/Dexamethasone Versus Single-Agent Therapies Ann. Pharmacother., May 1, 2006; 40(5): 873 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B Leslie and T. J Gan Meta-Analysis of the Safety of 5-HT3 Antagonists with Dexamethasone or Droperidol for Prevention of PONV Ann. Pharmacother., May 1, 2006; 40(5): 856 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Loewen, C. A. Marra, and P. J. Zed 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting Can J Anesth, October 1, 2000; 47(10): 1008 - 1018. [Abstract] [PDF]
|
|
|
|
|
|
I. Henzi, J. Sonderegger, and M. R. Tramer Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting Can J Anesth, June 1, 2000; 47(6): 537 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kranke, C. C. Apfel, N. Roewer, and Y. Fujii Reported Data on Granisetron and Postoperative Nausea and Vomiting by Fujii et al. Are Incredibly Nice! • Response Anesth. Analg., April 1, 2000; 90(4): 1004 - 1007. [Full Text] [PDF]
|
|
|
|
|
|
Y. Fujii, Y. Saitoh, H. Tanaka, and H. Toyooka Ramosetron for Preventing Postoperative Nausea and Vomiting in Women Undergoing Gynecological Surgery Anesth. Analg., February 1, 2000; 90(2): 472 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fujii, Y. Saitoh, H. Tanaka, and H. Toyooka Comparison of Ramosetron and Granisetron for Preventing Postoperative Nausea and Vomiting After Gynecologic Surgery Anesth. Analg., August 1, 1999; 89(2): 476 - 476. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
